Warning: Undefined array key "S1" in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Adalimumab ttTNFalpha.php on line 2
Adalimumab ttTNFalpha
LE WE PMID CA
Adalimumab ttTNFalpha4127Adalimumab ttTNFalpha

81C6 ttTenascin

Abatacept ttCTLA4Conjugate

Abciximab ttGPIIAIIIB

Adalimumab ttTNFalpha

AIN457

Alemtuzumab ttCD52

AMG386 ttAngiopoietin1 ttAngiopoietin2

Ankylosing spondylitis

Antibodies (therapeutic use)

Asthma (BASKET)

Atacicept ttBlys ttAPRIL

Bapineuzumab ttAmyloidBeta

Basiliximab ttIL2R

Belatacept ttCD80 ttCD86

Belimumab ttBLyS

Bevacizumab ttVEGF

Brentuximab vedotin ttCD30

Briakinumab ttIL12 ttIL23

Canakinumab ttIL1beta

Catumaxomab ttEpCAM ttCD3 linkerAb

Certolizumab ttTNFalpha

Cetuximab ttEGFR

Crohn s disease

Daclizumab ttIL2R

Dalotuzumab ttIGF1R

Denosumab ttRANKL

Eculizumab ttFactorH

Efalizumab ttLFA1

Epratuzumab ttCD22

Etanercept ttTNFalpha

FactorIXFc ttFactorIX

FactorVIIIFc ttFactorVIII

Farletuzumab ttFolateRalpha

Figitumumab ttIGF1R

Galiximab ttCD80

Gemtuzumab ozogamicin ttCD33

Girentuximab ttCarbonicAnhydraseIX

Golimumab ttTNFalpha

Ibritumomab tiuxentan yttrium ttCD20

Inflammatory bowel diseases

Infliximab ttTNFalpha

Inotuzumab ozogamicin ttCD22

Ipilimumab ttCTLA4

Mepolizumab ttIL5

Motavizumab ttRSVirus

MuromonabCD3 ttCD3

Naptumomab estafenatox tt5T4

Natalizumab ttIntegrinalpha4

Necitumumab ttEGFR

Nimotuzumab ttEGFR

Obinutuzumab ttCD20

Ocrelizumab ttCD20

Ofatumumab ttCD20

Omalizumab ttCD20

Otelixizumab ttCD3

Pagibaximab ttLipoteichoicAcidStaphlococcus

Palivizumab ttRSVirusFprotein

Panitumomab ttEGFR

Pertuzumab ttHER2

Psoriasis

Ramucirumab ttVEGFR2

Ranibizumab ttVEGF

Raxibacumab ttAnthrax

REGN88 ttIL6R

Reslizumab ttIL5

Rilonacept ttIL1R

Rituximab ttCD20

Solanezumab ttAmyloidBeta

T1H ttCD6

Tanezumab ttNGF

Teplizumab ttCD3

Tocilizumab ttIL6

Tositumomab ttCD20

Trastuzumab emtansine ttHER2

Trastuzumab ttHER2

Tremelimumab ttCLTA4

Tuberculosis

Ustekinumab ttIL12 ttIL23

Vedolizumab ttIntegrina4b7

Zalutumumab ttEGFR

Zanulimumab ttCD4

2009  
1
Targeted treatment of psoriasis with adalimumab: a critical appraisal based on a systematic review of the literature.
[19707417] Biologics 3(-): 303-18 (2009)
2008  
2
Adalimumab for the treatment of Crohn's disease.
[19707457] Biologics 2(4): 763-77 (2008)
2009  
3
Adalimumab for the treatment of psoriasis.
[19804689] Health Technol Assess 13 Suppl 2(): 49-54 (2009)
2009  
4
Adalimumab safety and mortality rates from global clinical trials of six immune-mediated inflammatory diseases.
[19147611] Ann Rheum Dis 68(12): 1863-9 (2009)
2006  
5
Eosinophilic cellulitis (Wells' syndrome) as a cutaneous reaction to the administration of adalimumab.
[16699060] Ann Rheum Dis 65(6): 839-40 (2006)
2009  
6
Systematic review: the short-term and long-term efficacy of adalimumab following discontinuation of infliximab.
[19681810] Aliment Pharmacol Ther 30(10): 977-86 (2009)
2009  
7
Early clinical experience with adalimumab in treatment of inflammatory bowel disease with infliximab-treated and naïve patients.
[19006540] Aliment Pharmacol Ther 29(3): 273-8 (2009)
2010  
8
Effectiveness of adalimumab in treating patients with active psoriatic arthritis and predictors of good clinical responses for arthritis, skin and nail lesions.
[19815494] Ann Rheum Dis 69(2): 394-9 (2010)
2009  
9
Adalimumab treatment of life-threatening tuberculosis.
[19364287] Clin Infect Dis 48(10): 1429-32 (2009)
2008  
10
2011  
11
Antibody-based therapeutics to watch in 2011.
[21051951] MAbs 3(1): 76-99 (2011)
2010  
12
Antibodies to watch in 2010.
[20065640] MAbs 2(1): 84-100 (2010)
2008  
13
Adalimumab in ankylosing spondylitis: an evidence-based review of its place in therapy.
[21221193] Core Evid 2(4): 295-305 (2008)
2011  
14
Update on the management of inflammatory bowel disease: specific role of adalimumab.
[21904462] Clin Exp Gastroenterol 4(-): 163-72 (2011)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.


Fatal error: Uncaught Error: Call to undefined function mysql_connect() in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Adalimumab ttTNFalpha.php:92 Stack trace: #0 {main} thrown in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Adalimumab ttTNFalpha.php on line 92